bpc 157 tb500 oral BPC-157/TB-500 Capsules Oral Liposomal BPC-157 • Peptides

Ruenzi et al., 2005) and in experimental rat studies (see Seiwerth et al., 2018), a point recently confirmed (Xu et al., 2020)

1,7 The underlying cause of Bells palsy is not known in most cases, but inflammation and reactivation of a dormant viral infection affecting the facial nerve, also called the cranial nerve VII, appear to be important contributing factors

Kisli M, Sacmaci H

Dosage: 60 to 100 mcg per day Frequency: Once daily or split into two doses Administration: Subcutaneous or intramuscular Cycle length: 4 to 6 weeks maximum Time off: Longer than time on Important: IGF-1 LR3 dosage should not exceed 100 mcg per day according to most research protocols